Research Topics
| Heidi TheetenSummaryAffiliation: University of Antwerp Country: Belgium Publications
| Collaborators
|
Detail Information
Publications
Lessons learned from a measles outbreak in Antwerp, Belgium 2007-2008Carine Asnong
School Health Center of the Province of Antwerp, Antwerp, Belgium
Pediatr Infect Dis J 30:343-5. 2011..Not only belief issues but difficulties to access the regular vaccination program also seem to be the main reason...
Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescentsH Theeten
WHO Collaborating Centre, Centre for the Evaluation of Vaccination, Epidemiology and Social Medicine, University of Antwerp, Universiteitsplein 1, B 2610 Antwerp, Belgium
Vaccine 23:1515-21. 2005..5-90.7%), fatigue (42.1-47.4%) and headache (41.1-45.1%). This study showed that the aluminium content has a specific influence on the immunogenicity of this dTpa vaccine...
Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in BelgiumH Theeten
Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
Epidemiol Infect 139:494-504. 2011..Despite free universal vaccination against MMR for more than 20 years and against diphtheria and tetanus for almost 60 years, our study revealed specific age groups remaining at risk for infection with these pathogens...
Coverage of recommended vaccines in children at 7-8 years of age in Flanders, BelgiumHeidi Theeten
Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, B 2610 Antwerp, Belgium
Acta Paediatr 98:1307-12. 2009..Meningococcal serogroup C and DT-polio vaccines offered respectively as catch-up and booster vaccinations were also evaluated...
Common attitudes about concomitant vaccine injections for infants and adolescents in Flanders, BelgiumHeidi Theeten
Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, B 2610 Antwerp, Belgium
Vaccine 27:1964-9. 2009..Work-loss due to vaccination was assessed for infants only and was rare (4.5%)...
Caregivers' willingness to pay to reduce the number of vaccine injections in infantsHeidi Theeten
Center for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
Pediatr Infect Dis J 28:61-3. 2009..These results suggest that more sophisticated methods are required, and similar analyses should exert a similar level of caution when presenting their results...
Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-surveyHeidi Theeten
Centre for the Evaluation of Vaccination, University of Antwerp, Universiteitsplein 1, B 2610 Antwerp, Belgium
Vaccine 25:4940-8. 2007....
Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus-toxoid vaccinesHeidi Theeten
University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium
Curr Med Res Opin 23:2729-39. 2007....
Vaccination coverage in 14-year-old adolescents: documentation, timeliness, and sociodemographic determinantsCorinne Vandermeulen
Center for Youth Health Care, Katholieke Universiteit Leuven, Kapucijnenvoer 35, B 3000 Leuven, Belgium
Pediatrics 121:e428-34. 2008..The objective of this study was to measure the coverage and influencing determinants of hepatitis B virus, measles-mumps-rubella, and Meningococcus serogroup C vaccination in 14-year-old adolescents in Flanders, Belgium, in 2005...
Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targetsAnthony Nardone
Centre for Infections, Health Protection Agency, London, England
Bull World Health Organ 86:118-25. 2008..To standardize serological surveillance to compare rubella susceptibility in Australia and 16 European countries, and measure progress towards international disease-control targets...
